ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Avidity Biosciences Inc

Avidity Biosciences Inc (RNA)

43.58
-0.07
( -0.16% )
更新日時: 01:52:33

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
43.58
買値
43.53
売値
43.68
出来高
270,798
42.30 日の範囲 44.68
5.68 52 週間の範囲 56.00
時価総額
前日終値
43.65
始値
43.86
最終取引時間
01:52:29
財務取引量
US$ 11,722,940
VWAP
43.2904
平均取引量 (3 か月)
1,256,085
発行済株式数
119,309,317
配当利回り
-
PER
-24.55
1 株当たり利益 (EPS)
-1.78
歳入
9.56M
純利益
-212.22M

Avidity Biosciences Inc について

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Avidity Biosciences Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker RNA. The last closing price for Avidity Biosciences was US$43.65. Over the last year, Avidity Biosciences shares have traded in a share price range of US$ 5.68 to US$ 56.00.

Avidity Biosciences currently has 119,309,317 shares in issue. The market capitalisation of Avidity Biosciences is US$5.21 billion. Avidity Biosciences has a price to earnings ratio (PE ratio) of -24.55.

RNA 最新ニュース

Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations

Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations PR...

Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights

Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights PR Newswire SAN DIEGO, Nov. 7, 2024 Enrollment in global Phase 3 HARBOR™ study for del-desiran in DM1 is on...

Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024

Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024 PR Newswire SAN...

Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy

Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-9.87-18.465855940153.4554.2439.5132169444.40897378CS
4-1.89-4.156586760545.475639.5109095246.10829476CS
12-0.34-0.77413479052843.925639.3509125608544.98121774CS
2614.5850.275862069295625.03142671042.08391564CS
5237.54621.5231788086.04565.68138220029.49966569CS
15615.756.3127690127.88564.82599815321.72465355CS
26024.93133.67292225218.65564.82575705222.13593128CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WORXSCWorx Corporation
US$ 2.07
(111.22%)
110.56M
CRNCCerence Inc
US$ 4.675
(65.78%)
35.57M
QUBTQuantum Computing Inc
US$ 5.095
(38.45%)
92.52M
SPAISafe Pro Group Inc
US$ 4.4123
(37.88%)
37.01M
IBGInnovation Beverage Group Limited
US$ 1.06
(33.97%)
9.6M
GLXGGalaxy Payroll Group Ltd
US$ 1.51
(-61.38%)
1.01M
PYXSPyxis Oncology Inc
US$ 2.10
(-45.03%)
10.14M
KURAKura Oncology Inc
US$ 9.92
(-37.65%)
8.27M
BLRXBioLineRx Ltd
US$ 0.355
(-34.89%)
6.39M
TMTCTMT Acquisition Corporation
US$ 4.52
(-29.81%)
18.84k
CDTConduit Pharmaceuticals Inc
US$ 0.112951
(22.37%)
499.7M
NVDANVIDIA Corporation
US$ 144.855
(-0.71%)
212.11M
AKTSAkoustis Technologies Inc
US$ 0.0985
(13.09%)
185.68M
ELABElevai Labs Inc
US$ 0.0201
(-6.07%)
175.91M
WORXSCWorx Corporation
US$ 2.07
(111.22%)
110.56M

RNA Discussion

投稿を表示

最近閲覧した銘柄